← Open Payments lookup

ULZIIBAT PERSON: Open Payments

NPI 1831607969 · HILO, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$870 in 6 payments from 3 companies in 2025. Trend: 2023 $178 · 2024 $33 · 2025 $870

Food & beverage: $870
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.3$461
Otsuka America Pharmaceutical, Inc.2$284
Teva Pharmaceuticals USA, Inc.1$125

Products named: INGREZZA, ABILIFY MAINTENA, ABILIFY ASIMTUFII, UZEDY.

Industry payments across HI — which companies pay providers there.